New York, New York (PRWEB) August 22, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that C.R. Bard has agreed to settle for an undisclosed amount the second trial regarding its Avaulta-branded vaginal mesh device, according to court documents. The trial began, and was settled on, the same date, Aug. 21, 2013, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Queen v. C.R. Bard Inc., Case No. 2:11-cv-00012).
The settlement occurs about one week after another federal jury awarded a total of $2 million in damages to a Georgia woman, having found that C.R. Bard Inc. had failed to warn of the potential dangers associated with its Avaulta-branded vaginal mesh device, according to court documents. On Thursday, Aug. 15, 2013, the jurors awarded the woman $250,000 in compensatory damages and $1.75 million in punitive damages. The trial had begun on July 29, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Cisson v. C.R. Bard Inc., Case No. 2:11-cv-00195).
“While we don’t know the amount of the settlement this time, we are hopeful that it will sufficiently help this claimant get the medical attention she may require in the future,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “And since the allegations in the first two trials are similar to what many women are alleging in the pending litigations, we are optimistic that there is a light at the end of the tunnel for all of those claimants injured by these products.”
Thousands of transvaginal mesh lawsuits have been formulated into six MDLs pending in U.S. District Court for the Southern District of West Virginia. The list is comprised of Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387; and In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440.
The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include:
The FDA also stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
Read the full story at http://www.prweb.com/releases/Bard_trial_settlement/08/prweb11054859.htm.
Copyright©2012 Vocus, Inc.
All rights reserved